Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk U Knowlton

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Frontiers in Cardiovascular Medicine|September 8, 2023
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular eventsViet T Le, Stacey Knight, Jeramie D Watrous, et al.
Circulation Research|April 30, 2020
Cardiomyocyte Expression of ZO-1 Is Essential for Normal Atrioventricular Conduction but Does Not Alter Ventricular FunctionJianlin Zhang, Kevin P Vincent, Angela K Peter, et al.
The Annals of Thoracic Surgery|September 8, 2020
Evaluation of Routine Coronary Angiography Before Pulmonary ThromboendarterectomyAmit K Pandey, Noel S Lee, Jamie Marsal, et al.
JCI Insight|July 27, 2018
Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortalityBenjamin D Horne, Joseph B Muhlestein, Sterling T Bennett, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2023
Obesity Variants in the GIPR Gene Are not Associated With Risk of Fracture or Bone Mineral DensityUnnur Styrkarsdottir, Vinicius Tragante, Lilja Stefansdottir, et al.
BMJ Open|March 25, 2022
Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohortBenjamin D Horne, Joseph R Bledsoe, Joseph B Muhlestein, et al.
JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
Stem Cell Reports|August 21, 2018
Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem CellsJennifer Veevers, Elie N Farah, Mirko Corselli, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Frontiers in Cardiovascular Medicine|September 8, 2023
Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular eventsViet T Le, Stacey Knight, Jeramie D Watrous, et al.
Circulation Research|April 30, 2020
Cardiomyocyte Expression of ZO-1 Is Essential for Normal Atrioventricular Conduction but Does Not Alter Ventricular FunctionJianlin Zhang, Kevin P Vincent, Angela K Peter, et al.
The Annals of Thoracic Surgery|September 8, 2020
Evaluation of Routine Coronary Angiography Before Pulmonary ThromboendarterectomyAmit K Pandey, Noel S Lee, Jamie Marsal, et al.
JCI Insight|July 27, 2018
Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortalityBenjamin D Horne, Joseph B Muhlestein, Sterling T Bennett, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2023
Obesity Variants in the GIPR Gene Are not Associated With Risk of Fracture or Bone Mineral DensityUnnur Styrkarsdottir, Vinicius Tragante, Lilja Stefansdottir, et al.
BMJ Open|March 25, 2022
Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohortBenjamin D Horne, Joseph R Bledsoe, Joseph B Muhlestein, et al.
JAMA Cardiology|July 24, 2024
Contribution of Clinical Trial Event Data by Data Source: A Prespecified Analysis of the ADAPTABLE Randomized Clinical TrialJennifer A Rymer, Hillary Mulder, Lisa M Wruck, et al.
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
Stem Cell Reports|August 21, 2018
Cell-Surface Marker Signature for Enrichment of Ventricular Cardiomyocytes Derived from Human Embryonic Stem CellsJennifer Veevers, Elie N Farah, Mirko Corselli, et al.
Pageof 14